Bizarre Patents
Smoking Cessation Lighter and Method
A lighter for tobacco products suppresses the urge to smoke by operant conditioning.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120027811 | Formulations of Viable Cells for Oral Delivery This invention relates to solid formulations for the oral delivery of live microbial cells which comprise dried viable cells and small amounts of a bile acid binding agent, for example, an anion exchange resin such as cholestyramine. The presence of bile acid binding ag... | 02/02/2012 |
| 20100272671 | Co-Therapy For Diabetic Conditions Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bigua... | 10/28/2010 |
| 20100233116 | ORGANIC COMPOUNDS The present invention provides heterocyclic derivatives hat modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encom... | 09/16/2010 |
| 20100129309 | AMINE POLYMER COMPOSITIONS A pharmaceutical composition for treating hyperphosphatemia can include polymers derived from multi-amine monomers and multifunctional monomers, where the multifunctional monomer includes more than one electrophilic group.... | 05/27/2010 |
| 20100055066 | Agent for prophylactic and/or therapeutic treatment of diabetes According to the present invention, an agent for prophylactic and/or therapeutic treatment of diabetes comprising a substance inhibiting activity of farnesoid X receptor as an active ingredient can be provided.... | 03/04/2010 |
| 20100021415 | COSMETIC USE OF ORGANIC RESINATES A cosmetic method for releasing an active principle in a controlled fashion to uninjured skin, as a function of the ion content in or on skin, by exchange with the ions, in order to provide at least one cosmetic benefit to the skin, the method includes applying onto ski... | 01/28/2010 |
| 20090004133 | Methods and compositions for phosphate binding The present invention provides improved methods and compositions for therapeutically controlling and/or reducing serum phosphate levels in animals and mammalian patients. The methods comprise administering to the patient an amount of a dendrimer composition effective to... | 01/01/2009 |
| 20080279808 | 2,3,4,5-Tetrahydroxy-6-Sulfooxy Hexanoic Acid, Pharmaceutically Acceptable Salts and Equilibrium Forms Thereof, Processes for Their Preparation, Pharmaceutical Compositions Comprising Such Compounds and Their Medical Use The invention relates to novel compounds of general formula I wherein M represents hydrogen, or a metallic cation, preferably an alkaline metal, or alkaline-earth metal, and n is equal to 1, 2 or 3. The present invention also comprises compounds of general formula I in ... | 11/13/2008 |
| 20070212325 | Insulin Resistance-Improving Agent A medicament comprising a pharmaceutically acceptable anion exchange resin as an active ingredient is provided which exhibits an insulin resistance-improving action regardless of volume of meal or glucose absorption from the gastrointestinal tract. ... | 09/13/2007 |
| 20070110706 | TREATMENT OF HYPERPHOSPHATEMIA USING CROSSLINKED SMALL MOLECULE AMINE POLYMERS Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting sol... | 05/17/2007 |
| 20070110707 | Method of treating diseases involving non-enzymatic glycation Methods for preventing or diminishing non-enzymatic glycation as well as methods for treating diseases involving non-enzymatic glycation are disclosed. The methods involve administering to a patient an agent that decreases serum inorganic phosphate levels. The agent can... | 05/17/2007 |
| 20070025953 | Co-therapy for diabetic conditions Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-admini... | 02/01/2007 |
| 20060269510 | Orlistat compositions A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity. ... | 11/30/2006 |
| 20060263327 | Method for the production of a stable injectable formulation made of difficult to dissolve antineoplastic active substances The invention relates to a method for the production of a stable injectable formulation of antineoplastic active substances which are difficult to dissolve. A formulation containing the antineoplastic active substance and a solvent and/or a solvent system containing, op... | 11/23/2006 |
| 20060251611 | Antibacterial processing of fiber products The invention provides an antibacterial processing agent for a fiber product comprising an inorganic antibacterial agent comprising an antibacterial metal carried on an inorganic carrier, The inorganic antibacterial agent is dispersed in water with an inorganic dispersi... | 11/09/2006 |
| 20060177414 | Pharmaceutical preparations for oral adminstration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents The present invention relates to pharmaceutical preparations for oral administration, comprising one or more active substances bound to an ion exchanger. In order to improve physical stability and acceptance, particularly in animals, a pseudoplastic gel-former thickener... | 08/10/2006 |
| 20060104941 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease The invention involves methods for characterizing an individual's risk profile of developing a future cardiovascular disorder by obtaining a level of the marker of systemic inflammation in the individual. The invention also involves methods for evaluating the likelihood... | 05/18/2006 |
| 20060083711 | Methods and products related to the intracellular delivery of polysaccharides The invention relates, in part, to methods and compositions for the intracellular delivery of polysaccharides. In particular, the methods and compositions relate to the intracellular delivery of glycosaminoglycans, such as heparin. The invention in other aspects relates... | 04/20/2006 |
| 20060051314 | Drug for prevention and/or treatment of constipation and sympton caused by constipation A medicament for preventive and/or therapeutic treatment of constipation and/or a symptom resulting from constipation which comprises magnesium polycarbophil as an active ingredient. The medicament of the present invention can exhibit high efficacy by promoting a normal... | 03/09/2006 |
| 20050265955 | Sustained release preparations Disclosed are sustained release drug particles suitable for forming sustained release oral pharmaceutical compositions. The sustained release drug particles comprise a drug-ion exchange resin complex and a water-permeable, diffusion barrier surrounding at least a portio... | 12/01/2005 |
| 20050256053 | Combined use of a GLP-1 compound and another drug for treating dyslipidemia Methods and uses for treatment of dyslipidemia comprising administration of a GLP-1 compound and another antidyslipidemic drug. ... | 11/17/2005 |
| 20050220755 | Topical composition based on ion-exchange resins, in particular for treating erythemas The object of the invention is a topical composition particularly for the treatment of erythema, characterized in that it includes at least one ion exchange resin such as colestyramine and at least one substance with buffer properties. ... | 10/06/2005 |
| 20050147580 | Anion-binding polymers and uses thereof Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting sol... | 07/07/2005 |
| 20050142097 | Multiple active drug resin conjugate A combination pharmaceutical preparation including two different active drugs of the same ionic charge conjugated with a single resin particle, without one significantly displacing the other, and without retarding the initial availability of either active. Also, methods... | 06/30/2005 |
| 20050136030 | Orlistat compositions A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity. ... | 06/23/2005 |
| 20050074424 | Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method A compound and method are provided for combining a chemotherapeutic drug with a polyion polymer for selective chemotherapy delivery. A glucose solution is combined with the polyion polymer, which allows the glucose solution and polyion polymer to be infused into a body ... | 04/07/2005 |
